Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 226,116,580 papers from all fields of science
Search
Sign In
Create Free Account
pamidronic acid
Known as:
Acido pamidronico
, Acidum pamidronicum
, Acide pamidronique
Expand
An amino- bisphosphonate with anti-resorptive and anti-hypercalcemic activities. Pamidronic acid binds to and adsorbs onto hydroxyapatite crystals in…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
6 relations
10 ML Pamidronate Disodium 3 MG/ML Injection
10 ML Pamidronate Disodium 9 MG/ML Injection
Pamidronate Disodium
Pamidronate Disodium 30 MG Injection
Expand
Broader (1)
pamidronate
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Role of intravenous dosage regimens of bisphosphonates in relation to other aetiological factors in the development of osteonecrosis of the jaws in patients with myeloma.
F. Jarnbring
,
Alireza Kashani
,
+4 authors
B. Lund
British Journal of Oral and Maxillofacial Surgery
2015
Corpus ID: 25729078
Review
2014
Review
2014
Which bisphosphonate to treat bone metastases?
L. Costa
The Lancet Oncology
2014
Corpus ID: 206139696
Review
2013
Review
2013
Clinical development of neridronate: potential for new applications
D. Gatti
,
M. Rossini
,
O. Viapiana
,
L. Idolazzi
,
S. Adami
Therapeutics and Clinical Risk Management
2013
Corpus ID: 5293664
Neridronate is an aminobisphosphonate, licensed in Italy for the treatment of osteogenesis imperfecta (OI) and Paget’s disease of…
Expand
2012
2012
Zoledronic Acid
Sohita Dhillon
,
K. Lyseng-Williamson
Drugs
2012
Corpus ID: 46974004
SummaryAbstractZoledronic acid (Zometa®), a third-generation amino-bisphosphonate, has been approved in the US, the EU and many…
Expand
2011
2011
Life-threatening hypercalcemia in patients with rhabdomyolysis-induced oliguric acute renal failure.
G. Graziani
,
A. Calvetta
,
D. Cucchiari
,
S. Valaperta
,
A. Montanelli
JN. Journal of Nephrology (Milano. )
2011
Corpus ID: 10105212
BACKGROUND In a third of patients presenting with rhabdomyolysis-induced acute renal failure (ARF), a biphasic plasma calcium…
Expand
Review
2008
Review
2008
Zoledronic acid: a pharmacoeconomic review of its use in the management of bone metastases.
K. McKeage
,
G. Plosker
PharmacoEconomics (Auckland)
2008
Corpus ID: 33153813
Zoledronic acid (Zometa is a third-generation nitrogen-containing parenteral bisphosphonate indicated for the treatment of bone…
Expand
2006
2006
Clinical response of cutaneous squamous-cell carcinoma to bortezomib given for myeloma.
K. Ramadan
,
K. Mckenna
,
T. C. Morris
The Lancet Oncology
2006
Corpus ID: 45195279
2006
2006
Long-Term Survival after Second-Line Therapy with Docetaxel and Carboplatin and Monthly Pamidronic Acid in a Woman with Metastatic Non-Small Cell Lung Cancer
B. Andritzky
,
G. Schuch
,
+4 authors
E. Laack
Oncology Research and Treatment
2006
Corpus ID: 29209248
Background: In patients with metastatic non-small cell lung cancer (NSCLC), second-line chemotherapy induces response rates of…
Expand
2003
2003
Posterior uveitis: an under-recognized adverse effect of pamidronate: 2 case reports.
G. Haverbeke
,
G. Pertile
,
C. Claes
,
Thierry Zeyen
Bulletin de la Societe belge d'ophtalmologie
2003
Corpus ID: 24067495
Ocular adverse effects of pamidronic acid are rare but well documented. Pamidronate, an inhibitor of bone resorption used…
Expand
1991
1991
Intravenous pamidronic acid in hypercalcemia due to parathyroid carcinoma.
E. Vega
,
C. Mautalen
Medicina
1991
Corpus ID: 46449896
Three patients aged between 31 and 59 were treated with pamidronic acid (APD) due to severe hypercalcemia caused by parathyroid…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE